IMM 20.3% 35.5¢ immutep limited

News: IMM Immutep Says Co Entered Into Clinical Trial Collaboration And Supply Agreement, page-21

  1. 25,349 Posts.
    lightbulb Created with Sketch. 1377

    Bioqld, just beat me too it mate......things on the up here .....see also

    in the Australian interview, Marc says " Efti " has been shown in limited

    trials to provide 20-30% success rate in mono therapy......Data due 2019

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.